Explore
Validate
LearnHPA027052
antibody from Atlas Antibodies
Targeting: GPER1
CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA027052 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA027052, RRID:AB_10612112
- Product name
- Anti-GPER1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human GPER1, Gene description: G protein-coupled estrogen receptor 1, Alternative Gene Names: CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR, Validated applications: IHC, Uniprot ID: Q99527, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
Nk3R blockade has sex-divergent effects on memory in mice
Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology
Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice
Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade
Lee I, Doepner M, Weissenrieder J, Majer A, Mercado S, Estell A, Natale C, Sung P, Foskett J, Carroll M, Ridky T
Cancer Research Communications 2023;3(8):1594-1606
Cancer Research Communications 2023;3(8):1594-1606
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
Hojnik M, Sinreih M, Anko M, Hevir-Kene N, Knific T, Pirš B, Grazio S, Rižner T
International Journal of Molecular Sciences 2023;24(3):3009
International Journal of Molecular Sciences 2023;24(3):3009
Han S, Mueller C, Wuebbolt C, Kilcullen S, Nayyar V, Calle Gonzalez B, Mahdavi Fard A, Floss J, Morales M, Patel S
2023
2023
Nk3R blockade has sex-divergent effects on memory in mice
Florido A, Moreno E, Canela E, Andero R
Biology of Sex Differences 2022;13(1)
Biology of Sex Differences 2022;13(1)
Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology
Yamamoto A, Yang L, Kuroda Y, Guo J, Teng L, Tsuruta D, Katayama I
International Journal of Molecular Sciences 2020;22(1):269
International Journal of Molecular Sciences 2020;22(1):269
Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
Natale C, Li J, Pitarresi J, Norgard R, Dentchev T, Capell B, Seykora J, Stanger B, Ridky T
Cellular and Molecular Gastroenterology and Hepatology 2020;10(4):868-880.e1
Cellular and Molecular Gastroenterology and Hepatology 2020;10(4):868-880.e1
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice
Liu M, Du Y, Li H, Wang L, Ponikwicka-Tyszko D, Lebiedzinska W, Pilaszewicz-Puza A, Liu H, Zhou L, Fan H, Wang M, You H, Wolczynnski S, Rahman N, Guo Y, Li X
Frontiers in Oncology 2019;9
Frontiers in Oncology 2019;9
Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade
Natale C, Li J, Zhang J, Dahal A, Dentchev T, Stanger B, Ridky T
eLife 2018;7
eLife 2018;7
No comments: Submit comment
No validations: Submit validation data